FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2077237452> ?p ?o ?g. }

• W2077237452 endingPage "70" @default.
• W2077237452 startingPage "61" @default.
• W2077237452 abstract "Many fungal toxins exhibit in vitro and in vivo antineoplastic effects on various cancer cell types. Luteoskyrin, a hydroxyanthraquinone has been proved to be a potent inhibitor against Ehrlich ascites tumor cells. The comparative antitumor activity and antioxidant status of MT81 and its structural analogue [Acetic acid-MT81 (Aa-MT81)] having polyhydroxyanthraquinone structure were assessed against Ehrlich ascites carcinoma (EAC ) tumor in mice. The in vitro cytotoxicity was measured by the viability of EAC cells after direct treatment of the said compounds. In in vivo study, MT81 and its structural analogue were administered (i.p.) at the two different doses (5, 7 mg MT81; 8.93, 11.48 mg Aa-MT81/kg body weight) for 7 days after 24 hrs. of tumor inoculation. The activities were assessed using mean survival time (MST), increased life span (ILS), tumor volume, viable tumor cell count, peritoneal cell count, protein percentage and hematological parameters. Antioxidant status was determined by malondialdehyde (MDA) and reduced glutathione (GSH ) content, and by the activity of superoxide dismutase (SOD) and catalase (CA T). MT81 and its structural analogues increased the mean survival time, normal peritoneal cell count. They decreased the tumor volume, viable tumor cell count, hemoglobin percentage and packed cell volume. Differential counts of WBC, total counts of RBC & WBC that altered by EAC inoculation, were restored in a dose-dependent manner. Increased MDA and decreased GSH content and reduced activity of SOD, and catalase in EAC bearing mice were returned towards normal after the treatment of MT81 and its structural analogue. Being less toxic than parent toxin MT81, the structural analogue showed more prominent antineoplastic activities against EAC cells compared to MT81. At the same time, both compounds exhibit to some extent antioxidant potential for the EAC-bearing mice." @default.
• W2077237452 created "2016-06-24" @default.
• W2077237452 creator A5005087999 @default.
• W2077237452 creator A5014537759 @default.
• W2077237452 creator A5074066680 @default.
• W2077237452 date "2010-01-01" @default.
• W2077237452 modified "2023-10-17" @default.
• W2077237452 title "Antineoplastic Activities of MT81 and Its Structural Analogue in Ehrlich Ascites Carcinoma-Bearing Swiss Albino Mice" @default.
• W2077237452 cites W121544642 @default.
• W2077237452 cites W1445103006 @default.
• W2077237452 cites W1507082667 @default.
• W2077237452 cites W1775749144 @default.
• W2077237452 cites W1912673154 @default.
• W2077237452 cites W1967487924 @default.
• W2077237452 cites W1972966092 @default.
• W2077237452 cites W1977364435 @default.
• W2077237452 cites W1993860444 @default.
• W2077237452 cites W2005717353 @default.
• W2077237452 cites W2008035030 @default.
• W2077237452 cites W2019152871 @default.
• W2077237452 cites W2028488274 @default.
• W2077237452 cites W2035726243 @default.
• W2077237452 cites W2037435762 @default.
• W2077237452 cites W2039333096 @default.
• W2077237452 cites W2066873661 @default.
• W2077237452 cites W2071071098 @default.
• W2077237452 cites W2082291281 @default.
• W2077237452 cites W2088866343 @default.
• W2077237452 cites W2106787323 @default.
• W2077237452 cites W2110421117 @default.
• W2077237452 cites W2116770453 @default.
• W2077237452 cites W2118986388 @default.
• W2077237452 cites W2127028977 @default.
• W2077237452 cites W2140841363 @default.
• W2077237452 cites W2157263222 @default.
• W2077237452 cites W2290809075 @default.
• W2077237452 cites W2293886385 @default.
• W2077237452 cites W2339136233 @default.
• W2077237452 cites W2403868247 @default.
• W2077237452 cites W2411152196 @default.
• W2077237452 cites W2411447833 @default.
• W2077237452 cites W2468312889 @default.
• W2077237452 cites W43257299 @default.
• W2077237452 doi "https://doi.org/10.4161/oxim.3.1.10495" @default.
• W2077237452 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2835890" @default.
• W2077237452 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20716929" @default.
• W2077237452 hasPublicationYear "2010" @default.
• W2077237452 type Work @default.
• W2077237452 sameAs 2077237452 @default.
• W2077237452 citedByCount "11" @default.
• W2077237452 countsByYear W20772374522012 @default.
• W2077237452 countsByYear W20772374522013 @default.
• W2077237452 countsByYear W20772374522015 @default.
• W2077237452 countsByYear W20772374522016 @default.
• W2077237452 countsByYear W20772374522018 @default.
• W2077237452 countsByYear W20772374522019 @default.
• W2077237452 countsByYear W20772374522022 @default.
• W2077237452 crossrefType "journal-article" @default.
• W2077237452 hasAuthorship W2077237452A5005087999 @default.
• W2077237452 hasAuthorship W2077237452A5014537759 @default.
• W2077237452 hasAuthorship W2077237452A5074066680 @default.
• W2077237452 hasBestOaLocation W20772374521 @default.
• W2077237452 hasConcept C150903083 @default.
• W2077237452 hasConcept C16685009 @default.
• W2077237452 hasConcept C181199279 @default.
• W2077237452 hasConcept C185592680 @default.
• W2077237452 hasConcept C202751555 @default.
• W2077237452 hasConcept C203014093 @default.
• W2077237452 hasConcept C207001950 @default.
• W2077237452 hasConcept C2775838275 @default.
• W2077237452 hasConcept C2776197502 @default.
• W2077237452 hasConcept C2778004101 @default.
• W2077237452 hasConcept C2778401633 @default.
• W2077237452 hasConcept C2778979269 @default.
• W2077237452 hasConcept C538909803 @default.
• W2077237452 hasConcept C55493867 @default.
• W2077237452 hasConcept C71924100 @default.
• W2077237452 hasConcept C86803240 @default.
• W2077237452 hasConcept C98274493 @default.
• W2077237452 hasConceptScore W2077237452C150903083 @default.
• W2077237452 hasConceptScore W2077237452C16685009 @default.
• W2077237452 hasConceptScore W2077237452C181199279 @default.
• W2077237452 hasConceptScore W2077237452C185592680 @default.
• W2077237452 hasConceptScore W2077237452C202751555 @default.
• W2077237452 hasConceptScore W2077237452C203014093 @default.
• W2077237452 hasConceptScore W2077237452C207001950 @default.
• W2077237452 hasConceptScore W2077237452C2775838275 @default.
• W2077237452 hasConceptScore W2077237452C2776197502 @default.
• W2077237452 hasConceptScore W2077237452C2778004101 @default.
• W2077237452 hasConceptScore W2077237452C2778401633 @default.
• W2077237452 hasConceptScore W2077237452C2778979269 @default.
• W2077237452 hasConceptScore W2077237452C538909803 @default.
• W2077237452 hasConceptScore W2077237452C55493867 @default.
• W2077237452 hasConceptScore W2077237452C71924100 @default.
• W2077237452 hasConceptScore W2077237452C86803240 @default.
• W2077237452 hasConceptScore W2077237452C98274493 @default.
• W2077237452 hasIssue "1" @default.
• W2077237452 hasLocation W20772374521 @default.

• next